arrow_back Back to App

Easier Access to Medications for Seniors: Doctor's Office Drug Dispensing.

This law temporarily (until the end of 2030) allows physicians participating in Medicare to dispense certain outpatient prescription drugs (Part D medications) directly from their practice. This aims to improve convenience and access for seniors, provided the patient has an established relationship and recent in-person visit with the doctor. The change is subject to government oversight to prevent conflicts of interest.
Key points
Doctors can dispense specific Medicare Part D drugs directly from their offices (or via mail) between 2026 and 2030, increasing convenience for beneficiaries.
To qualify, the patient must have an ongoing relationship and a recent face-to-face visit with the prescribing physician.
The government will study the impact of this change to ensure it does not lead to over-prescribing or unfair competition among pharmacies.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_2484
Sponsor: Rep. Harshbarger, Diana [R-TN-1]
Process start date: 2025-03-31
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-flash-latest
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Seniors’ Access to Critical Medications Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_2484.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-03-31.

What are the main provisions?

Key points include:

  • Doctors can dispense specific Medicare Part D drugs directly from their offices (or via mail) between 2026 and 2030, increasing convenience for beneficiaries.
  • To qualify, the patient must have an ongoing relationship and a recent face-to-face visit with the prescribing physician.
  • The government will study the impact of this change to ensure it does not lead to over-prescribing or unfair competition among pharmacies.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Harshbarger, Diana [R-TN-1].

What is the latest detailed status?

The latest detailed status is: Ordered to be Reported by the Yeas and Nays: 38 - 7.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health Benefits